Sección para completar los datos relacionados con las publicaciones que sirven de base al protocolo. Refiera hasta un máximo de 10 referencias.
Referencias:
1. International Adjuvant Lung Cancer Trial (IALT) Collaborative Group. Cispaltin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer. N Engl J Med 350:351-360, 2004.
2. Neninger E, Diaz RM, de la Torre A, Saurez G, Gabri MR, Alonso DS, Wilkinson B, Alfonso AM, Crombet T, Perez R, Vázquez AM. Active immunotherapy with 1E10 anti‑idiotype vaccine in patients with small cell lung cancer. Report of a Phase I Trial Cancer Biol Ther. 6:145‑150, 2007.3.
3. NSCLC Meta-analyses Collaborative Group. Adyuvant chemotherapy, with or without postoperative radiotherapy, in operable non-small-cell lung cancer: two meta-analyses of individual patient data. Lancet 375: 1267-1277, 2010.
4. Pignon J-P, Tribodet H, Scagliotti GV, Douillard J-I, Shepherd FA, Stephens RJ, Dunant A, Torri V, Rosell R, Seymour L, Spiro SG, Rolland E, Fossati R, Aubert D, Ding K, Waller D, Le Chevalier T. Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group. J Clin Oncol 26:3552 3559, 2008.